Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8188 |
Intermediate Similarity |
NPD7236 |
Approved |
0.8039 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.8025 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7724 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7706 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7616 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7602 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7557 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7544 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD6190 |
Approved |
0.716 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7086 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD7094 |
Approved |
0.7071 |
Intermediate Similarity |
NPD6858 |
Approved |
0.7066 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6287 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.703 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7029 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7014 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.6988 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6975 |
Remote Similarity |
NPD5403 |
Approved |
0.6972 |
Remote Similarity |
NPD5951 |
Approved |
0.6972 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD6801 |
Discontinued |
0.697 |
Remote Similarity |
NPD37 |
Approved |
0.6957 |
Remote Similarity |
NPD5401 |
Approved |
0.6946 |
Remote Similarity |
NPD4965 |
Approved |
0.6946 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD4966 |
Approved |
0.6932 |
Remote Similarity |
NPD8313 |
Approved |
0.6932 |
Remote Similarity |
NPD8312 |
Approved |
0.6928 |
Remote Similarity |
NPD7713 |
Phase 3 |
0.6927 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD3748 |
Approved |
0.6919 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6918 |
Remote Similarity |
NPD7003 |
Approved |
0.6914 |
Remote Similarity |
NPD6765 |
Approved |
0.6914 |
Remote Similarity |
NPD6764 |
Approved |
0.6911 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.6898 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6898 |
Remote Similarity |
NPD8319 |
Approved |
0.6894 |
Remote Similarity |
NPD6799 |
Approved |
0.6864 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6857 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6848 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6839 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6828 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6818 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6815 |
Remote Similarity |
NPD1238 |
Approved |
0.6803 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6803 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6803 |
Remote Similarity |
NPD5126 |
Approved |
0.68 |
Remote Similarity |
NPD5667 |
Approved |
0.6786 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD7228 |
Approved |
0.6776 |
Remote Similarity |
NPD6535 |
Approved |
0.6776 |
Remote Similarity |
NPD6534 |
Approved |
0.6772 |
Remote Similarity |
NPD2438 |
Suspended |
0.6765 |
Remote Similarity |
NPD919 |
Approved |
0.676 |
Remote Similarity |
NPD6785 |
Approved |
0.676 |
Remote Similarity |
NPD6784 |
Approved |
0.6755 |
Remote Similarity |
NPD7497 |
Discontinued |
0.675 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6748 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6747 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6744 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6743 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6739 |
Remote Similarity |
NPD164 |
Approved |
0.6726 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6719 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6719 |
Remote Similarity |
NPD7874 |
Approved |
0.671 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6708 |
Remote Similarity |
NPD3750 |
Approved |
0.6708 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD7411 |
Suspended |
0.6705 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6691 |
Remote Similarity |
NPD7798 |
Approved |
0.6688 |
Remote Similarity |
NPD7095 |
Approved |
0.6687 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD3226 |
Approved |
0.6684 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD5408 |
Approved |
0.6667 |
Remote Similarity |
NPD7697 |
Approved |
0.6667 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3887 |
Approved |
0.6667 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5404 |
Approved |
0.6667 |
Remote Similarity |
NPD7698 |
Approved |
0.6667 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD2796 |
Approved |
0.6667 |
Remote Similarity |
NPD5405 |
Approved |
0.6667 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5406 |
Approved |
0.6647 |
Remote Similarity |
NPD3882 |
Suspended |
0.6647 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6645 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6643 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6632 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6632 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6629 |
Remote Similarity |
NPD7240 |
Approved |
0.6629 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6629 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6627 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6627 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6625 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6625 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6625 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6623 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6603 |
Remote Similarity |
NPD6663 |
Approved |
0.6596 |
Remote Similarity |
NPD6779 |
Approved |
0.6596 |
Remote Similarity |
NPD6782 |
Approved |
0.6596 |
Remote Similarity |
NPD6780 |
Approved |
0.6596 |
Remote Similarity |
NPD6776 |
Approved |
0.6596 |
Remote Similarity |
NPD6781 |
Approved |
0.6596 |
Remote Similarity |
NPD6778 |
Approved |
0.6596 |
Remote Similarity |
NPD6777 |
Approved |
0.6592 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6592 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6591 |
Remote Similarity |
NPD3751 |
Discontinued |
0.659 |
Remote Similarity |
NPD1247 |
Approved |
0.659 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6585 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6564 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6562 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6561 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6558 |
Remote Similarity |
NPD5736 |
Approved |
0.6556 |
Remote Similarity |
NPD3972 |
Approved |
0.6547 |
Remote Similarity |
NPD1929 |
Approved |
0.6547 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6547 |
Remote Similarity |
NPD1930 |
Approved |
0.6545 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6545 |
Remote Similarity |
NPD2533 |
Approved |
0.6545 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6545 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6545 |
Remote Similarity |
NPD2534 |
Approved |
0.6545 |
Remote Similarity |
NPD2532 |
Approved |
0.6541 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6536 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6529 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6528 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6522 |
Remote Similarity |
NPD5763 |
Approved |
0.6522 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6522 |
Remote Similarity |
NPD5762 |
Approved |
0.6514 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6513 |
Remote Similarity |
NPD7801 |
Approved |
0.6512 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6512 |
Remote Similarity |
NPD3749 |
Approved |
0.65 |
Remote Similarity |
NPD1237 |
Approved |
0.65 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6497 |
Remote Similarity |
NPD7715 |
Approved |
0.6497 |
Remote Similarity |
NPD7714 |
Approved |
0.6497 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6494 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.648 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6471 |
Remote Similarity |
NPD1934 |
Approved |
0.6471 |
Remote Similarity |
NPD1876 |
Approved |
0.6467 |
Remote Similarity |
NPD920 |
Approved |
0.6458 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6456
|
Remote Similarity |
NPD4307 |
Phase 2 |